Skip to main content
. 2022 Sep 12;13:943812. doi: 10.3389/fphar.2022.943812

FIGURE 4.

FIGURE 4

The mean cumulative fecal (A) and urine (B) excretion of apatinib in rat presence or absence abdominal X-ray irradiation after intragastrical administration of 45 mg/kg (Mean ± SD, n = 3). The t-test was used for data analysis between the two groups. * significantly different from the absence X-ray irradiation group at p < 0.05, ** significantly different from the absence X-ray irradiation group at p < 0.01.